Dominique Figarella-Branger Selected Research

Proteins (Proteins, Gene)

1/2019	Inhibitor of Apoptosis Proteins Determines Glioblastoma Stem-Like Cell Fate in an Oxygen-Dependent Manner.
1/2018	Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome.
2/2016	Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas.
1/2016	Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling.
8/2015	Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomas.
12/2014	End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo.
5/2014	MALDI imaging and in-source decay for top-down characterization of glioblastoma.
10/2010	Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience.
9/2010	Absence of R140Q mutation of isocitrate dehydrogenase 2 in gliomas and breast cancers.
6/2010	Epidermal growth factor receptor in glioblastomas: correlation between gene copy number and protein expression.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominique Figarella-Branger Research Topics

Disease

90	Neoplasms (Cancer) 04/2024 - 05/2003
41	Glioblastoma (Glioblastoma Multiforme) 12/2023 - 05/2004
36	Glioma (Gliomas) 01/2024 - 02/2003
15	Astrocytoma (Pilocytic Astrocytoma) 01/2021 - 11/2002
10	Meningioma (Meningiomas) 04/2024 - 08/2005
10	Medulloblastoma 01/2022 - 04/2009
10	Pituitary Neoplasms (Pituitary Adenoma) 09/2017 - 05/2003
9	Adenoma (Adenomas) 11/2022 - 05/2003
8	Ependymoma 04/2024 - 10/2003
8	Oligodendroglioma 06/2023 - 11/2002
8	Brain Neoplasms (Brain Tumor) 01/2023 - 02/2003
7	Carcinogenesis 07/2023 - 08/2009
5	Acromegaly 11/2022 - 05/2003
5	Growth Hormone-Secreting Pituitary Adenoma 06/2021 - 09/2007
5	Necrosis 12/2019 - 08/2009
5	Neoplasm Metastasis (Metastasis) 05/2013 - 05/2003
4	Disease Progression 06/2022 - 05/2004
4	Pituitary ACTH Hypersecretion 08/2017 - 10/2006
4	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 01/2017 - 02/2003
4	Hypoxia (Hypoxemia) 02/2016 - 09/2010
4	Inflammation (Inflammations) 04/2014 - 12/2003
4	Muscular Diseases (Myopathy) 11/2010 - 11/2005
3	Primitive Neuroectodermal Tumors (PNET) 12/2018 - 09/2012
3	Ganglioglioma 01/2018 - 09/2013
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2017 - 05/2003
3	Myositis (Idiopathic Inflammatory Myopathies) 01/2013 - 12/2003
3	ACTH-Secreting Pituitary Adenoma 09/2010 - 07/2003
3	Dysferlinopathy 02/2009 - 08/2005
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2013
2	Genomic Instability 12/2019 - 05/2014
2	Dermatomyositis (Dermatopolymyositis) 01/2013 - 08/2008
2	Seizures (Absence Seizure) 10/2012 - 01/2012
2	Drug Resistant Epilepsy 10/2012 - 11/2009
2	Carcinoma (Carcinomatosis) 10/2010 - 05/2003

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2005
14	Messenger RNA (mRNA)IBA 01/2022 - 07/2003
12	Temozolomide (Temodar)FDA LinkGeneric 11/2022 - 05/2004
12	Biomarkers (Surrogate Marker)IBA 06/2022 - 10/2009
10	Octreotide (Sandostatin)FDA LinkGeneric 11/2022 - 09/2007
9	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 09/2012
9	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2022 - 12/2008
9	ProlactinIBA 01/2016 - 05/2003
8	Bevacizumab (Avastin)FDA Link 04/2022 - 05/2012
7	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 09/2010
6	RNA (Ribonucleic Acid)IBA 06/2023 - 10/2018
6	Somatostatin Receptors (Somatostatin Receptor)IBA 11/2022 - 12/2008
5	Growth Hormone (Somatotropin)IBA 06/2021 - 05/2003
5	Formaldehyde (Formol)FDA Link 01/2019 - 11/2015
5	ParaffinIBA 01/2019 - 11/2015
5	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 03/2010 - 05/2003
4	2,6-dinitrotoluene (DNT)IBA 10/2022 - 01/2012
4	Irinotecan (Camptosar)FDA LinkGeneric 04/2022 - 05/2012
4	Everolimus FDA Link 01/2021 - 08/2015
4	AntibodiesIBA 10/2013 - 12/2007
4	AdrenomedullinIBA 07/2011 - 04/2005
3	SynaptophysinIBA 01/2023 - 10/2006
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 03/2010
3	Mitochondrial DNA (mtDNA)IBA 01/2022 - 02/2008
3	Dopamine (Intropin)FDA LinkGeneric 06/2021 - 01/2012
3	Carmustine (FIVB)FDA Link 01/2021 - 10/2009
3	TubulinIBA 02/2020 - 02/2013
3	Histones (Histone)IBA 01/2020 - 10/2016
3	VimentinIBA 05/2019 - 10/2006
3	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2016 - 04/2008
3	Protein Isoforms (Isoforms)IBA 02/2013 - 11/2002
3	Dopamine Agonists (Dopamine Agonist)IBA 05/2012 - 04/2010
3	DysferlinIBA 02/2009 - 08/2005
2	EnzymesIBA 07/2023 - 12/2011
2	Procarbazine (Matulane)FDA Link 01/2023 - 01/2021
2	CateninsIBA 01/2023 - 11/2020
2	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 01/2021
2	Lomustine (CCNU)FDA Link 01/2023 - 01/2021
2	LigandsIBA 11/2022 - 08/2009
2	pasireotideIBA 11/2022 - 08/2017
2	EpitopesIBA 04/2022 - 08/2019
2	SteroidsIBA 02/2022 - 08/2011
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2022 - 03/2014
2	ProdrugsIBA 02/2020 - 11/2016
2	lisavanbulinIBA 02/2020 - 11/2016
2	BAL27862IBA 02/2020 - 11/2016
2	somatostatin receptor 2IBA 01/2020 - 01/2018
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2019 - 01/2018
2	ProscillaridinIBA 01/2018 - 11/2014
2	GlucocorticoidsIBA 02/2016 - 09/2010
2	Codon (Codons)IBA 01/2016 - 12/2011
2	Neurofibromin 2 (Merlin)IBA 08/2015 - 01/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2014 - 01/2014
2	CalciumIBA 02/2013 - 11/2005
2	Alkylating AgentsIBA 06/2012 - 10/2009
2	Glial Fibrillary Acidic ProteinIBA 02/2012 - 06/2009
2	Hormones (Hormone)IBA 10/2010 - 04/2008
2	polysialic acidIBA 03/2010 - 09/2007

Therapy/Procedure

29	Drug Therapy (Chemotherapy) 12/2023 - 05/2004
29	Radiotherapy 06/2023 - 10/2003
27	Therapeutics 01/2023 - 12/2003
3	Aftercare (After-Treatment) 06/2023 - 07/2010
3	Electrodes (Electrode) 01/2016 - 11/2009
3	Adjuvant Radiotherapy 09/2010 - 05/2007
2	Precision Medicine 06/2022 - 12/2018
2	Craniospinal Irradiation 12/2018 - 04/2009